Given these knowledge gaps, this study aims to investigate the combinatorial effects of DDR1 inhibition and CIR on tumor cell eradication and immune regulation in HNSCC, and explored the mechanisms underlying their antitumor efficacy, involved in AKT/mTOR signaling and immunogenic ferroptosis pathway. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.